Distribution of BPA and metabolic assessment in glioblastoma patients during BNCT treatment: a microdialysis study.
Boron neutron capture therapy (BNCT) is dependent on the selective accumulation of boron-10 in tumour cells. To maximise the radiation effect, the neutrons should be delivered when the ratio between the boron concentration in tumour cells to that in normal tissues reaches maximum. However, the pharmacokinetics of p-boronophenylalanine (BPA) and other boron delivery agents are only partly known. We used microdialysis to investigate the extracellular in vivo kinetics of boron in three intracerebral compartments -- solid tumour, brain adjacent to tumour (BAT), and the normal brain, as well as the subcutaneous tissue before, during, and after BNCT treatment. The findings were compared to the pharmacokinetics of BPA in the blood. We also measured the glucose metabolism and the levels of glutamate and glycerol in those compartments. Four patients were studied, two patients underwent surgical tumour resection and in two a stereotactic biopsy was performed. The patients were given BPA (900 mg/kg body weight) by a 6-h infusion. The infusion was completed approximately 2-3 h before neutron irradiation. In tumour tissue the extracellular concentration of BPA followed that of blood with a maximal concentration of 31.2 ppm and a maximal ratio vs. blood of 1.07. In BAT, the maximal concentration of BPA was 18.0 ppm with the peak level delayed for 4-6 h compared to the peak in blood with a maximal ratio of 1.2. Maximal blood concentration found was 41.0 ppm. The uptake of BPA in the normal brain was considerably lower than that in the blood and tumour tissue. No change in glucose metabolism was observed. The extracellular level of glycerol was increased after treatment in tumour tissue but not in normal brain suggesting a selective acute cytotoxic effect of BNCT on tumour cells.
Bergenheim
A Tommy
AT
Department of Neurosurgery, Umeå University Hospital, Umeå, Sweden. tommy.bergenheim@neuro.umu.se
Capala
Jacek
J
Roslin
Michael
M
Henriksson
Roger
R
D001786:Blood Glucose / Q000378:metabolism; D001896:Boron Compounds / Q000493:pharmacokinetics* / Q000627:therapeutic use; D016754:Boron Neutron Capture Therapy; D001921:Brain / Q000378:metabolism* / Q000528:radiation effects; D001932:Brain Neoplasms / Q000378:metabolism* / Q000532:radiotherapy; D005909:Glioblastoma / Q000378:metabolism* / Q000532:radiotherapy; D006801:Humans; D017551:Microdialysis; D010649:Phenylalanine / Q000031:analogs & derivatives* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D011838:Radiation-Sensitizing Agents / Q000493:pharmacokinetics*
D001786:Blood Glucose; D001896:Boron Compounds; D011838:Radiation-Sensitizing Agents; D010649:Phenylalanine; C033685:4-boronophenylalanine
Radiat Res. 1998 Feb;149(2):163-70
9457896
Phys Med Biol. 2003 Apr 21;48(8):1027-39
12741499
J Neurochem. 1999 Jan;72(1):129-38
9886063
Radiat Res. 1996 Nov;146(5):554-60
8896582
Radiat Res. 1982 Jul;91(1):77-94
7100396
J Neurooncol. 1992 Oct;14 (2):177-87
1331351
J Neurol Neurosurg Psychiatry. 1998 Apr;64(4):486-91
9576540
Radiat Res. 2002 Jun;157(6):700-10
12005550
Acta Neurochir Suppl. 2002;81:355-7
12168346
Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics. 2000 Jul;62(1 Pt B):1110-8
11088567
J Neurooncol. 1999 Feb;41(3):213-21
10359141
J Neurooncol. 2003 Mar-Apr;62(1-2):187-95
12749713
J Neurooncol. 2003 Mar-Apr;62(1-2):135-44
12749709
J Neurosurg. 1996 Dec;85(6):1056-65
8929495
J Neurooncol. 2002 Sep;59(2):135-42
12241106
Neurology. 1980 Sep;30(9):907-11
6252514
Acta Anaesthesiol Scand. 2001 Sep;45(8):977-85
11576049
Phys Med Biol. 2002 Mar 7;47(5):737-45
11931468
J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):455-61
11561027
J Neurooncol. 2003 Jan;61(2):151-60
12622454
J Neurooncol. 2003 Mar-Apr;62(1-2):111-21
12749707
Radiat Res. 2000 Feb;153(2):173-80
10629616
J Neurooncol. 2003 Mar-Apr;62(1-2):123-34
12749708
Anesthesiology. 2003 Apr;98(4):809-14
12657839
Neurosurgery. 1999 Jun;44(6):1182-92; discussion 1192-3
10371617
J Neurooncol. 2003 Mar-Apr;62(1-2):145-56
12749710
Radiat Res. 1987 Jul;111(1):14-25
3602351
J Neurooncol. 2003 Mar-Apr;62(1-2):171-86
12749712
J Neurosurg. 2001 May;94(5):740-9
11354405
J Neurooncol. 2003 Mar-Apr;62(1-2):157-69
12749711
Radiat Res. 1970 Sep;43(3):534-53
5460394
Neuroreport. 1997 Apr 14;8(6):1457-61
9172153
Acta Neuropathol. 2002 Jul;104(1):85-91
12070669
Stroke. 1995 May;26(5):870-3
7740581
Int J Radiat Oncol Biol Phys. 2003 Mar 1;55(3):743-56
12573762
J Neurooncol. 2003 Mar-Apr;62(1-2):101-9
12749706
Int J Radiat Oncol Biol Phys. 1998 Jun 1;41(3):631-8
9635713
Med Phys. 1999 Jul;26(7):1230-6
10435522
Int J Radiat Biol. 1991 Jul-Aug;60(1-2):125-30
1677960
Cancer Res. 1996 Oct 1;56(19):4302-6
8813111